Jamaican Initiative to Expand Alzheimer's Blood Testing Access
A new regional initiative has been launched to expand access to advanced blood testing for Alzheimer's disease in Jamaica. This program, stemming from a partnership between US-based companies C2N Diagnostics and SouthGenetics, aims to improve early detection and management of Alzheimer's by providing healthcare professionals with access to blood tests designed to identify amyloid plaques in the brain. These plaques are a key hallmark of Alzheimer's disease. The initiative also includes other countries such as Argentina, Chile, Colombia, the Dominican Republic, Ecuador, Mexico, Uruguay, and Venezuela. The tests will be available through qualified healthcare professionals and are intended to complement clinical assessments rather than replace them. 
